Cargando…
The time-to-treatment concept in acute heart failure: Lessons and implications from REALITY-AHF
Acute heart failure (AHF) is a clinical syndrome with devastating prognosis. Despite considerable improvements in the treatment of chronic heart failure, most trials of new drugs for AHF, such as vasodilators, inotropes, and diuretics, have failed to show a prognostic benefit. Therefore, pharmacolog...
Autores principales: | Kagiyama, Nobuyuki, Matsue, Yuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237952/ https://www.ncbi.nlm.nih.gov/pubmed/30088487 http://dx.doi.org/10.14744/AnatolJCardiol.2018.88935 |
Ejemplares similares
-
Larissa Heart Failure Risk Score and Mode of Death in Acute Heart Failure: Insights from REALITY-AHF
por: Xanthopoulos, Andrew, et al.
Publicado: (2023) -
Tolvaptan Add-on Therapy to Overcome Loop Diuretic Resistance in Acute Heart Failure With Renal Dysfunction (DR-AHF): Design and Rationale
por: Minh, Nhat Giang, et al.
Publicado: (2022) -
Clinical implication of initial intravenous diuretic dose for acute decompensated heart failure
por: Yoshioka, Kenji, et al.
Publicado: (2022) -
Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study
por: Metra, Marco, et al.
Publicado: (2010) -
Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF
por: Metra, Marco, et al.
Publicado: (2013)